Capital Change Notice - Issue of Performance Share Rights

13 September 2023
Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Performance Share Rights to acquire ordinary shares in the Company (‘PSRs’) issued under the Fisher & Paykel Healthcare 2022 Performance Share Rights Plan (‘PSR Plan’), the 2022 Sub-Plan for France (‘Sub-Plan for France’) and the Fisher & Paykel Healthcare 2022 Performance Share Rights Plan – North America (‘North America Plan’).

Section 1: Issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of financial product Unlisted PSRs issued under the PSR Plan, the Sub-Plan for France and the North America Plan.
ISIN (If unknown, check on NZX website) NZFAPE0001S2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 400,683
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security No amount is payable for the grant of PSRs. One PSR gives the participant the potential to exercise that PSR for one ordinary share at no cost.
Nature of the payment (for example, cash or other consideration) Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 400,683 PSRs represent approximately 0.06887% of the ordinary shares on issue
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) Not Applicable
Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) Issue of PSRs under the PSR Plan, the Sub-Plan for France and the North America Plan to incentivise selected employees to grow the Company and to attract, motivate and retain key employees.
Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption. 1,319,786 PSRs
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made Directors’ resolution dated 29 August 2023.
Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) The PSRs will be issued on the terms of the PSR Plan, the Sub-Plan for France and the North America Plan, as approved by the Board.
Date of issue/acquisition/redemption 12 September 2023
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Raelene Leonard
Contact person for this announcement Raelene Leonard
Contact phone number +64 9 574 0147
Contact email address [email protected]
Date of release through MAP 13 September 2023

---

Announcement PDF